Abstract
To evaluate effects of multiple dosing of ketoconazole (KTZ) on hepatic CYP3A, the pharmacokinetics of intravenous midazolam (MDZ, 0.5 mg/kg) before and during multiple dosing of KTZ were investigated in beagle dogs. KTZ tablets were given orally to dogs (n = 4) for 30 days (200 mg b.i.d.). With coadministration of KTZ, t1/2β of MDZ were significantly increased both on day 1 (2-fold) and on day 30 (3-fold). Total body clearance (CLtot) of MDZ declined gradually during the first 5 days after the start of KTZ treatment, and thereafter CLtot appeared to reach a plateau phase (one-fourth), depending on plasma KTZ concentrations. The effects of KTZ on the biotransformation of MDZ were also investigated using dog liver microsomes (n = 5). TheKi values of KTZ for MDZ 1′-hydroxylation and 4-hydroxylation were 0.0237 and 0.111 μM, respectively, indicating that KTZ extensively inhibits hepatic CYP3A activity in dogs. CLtot values estimated from in vitroKi values corrected by unbound fraction of KTZ and unbound concentrations of the drug in plasma were consistent with in vivo CLtot of MDZ. The results in this study suggest that KTZ treatment is necessary until plasma concentrations of the drug reach a steady state to evaluate the effect of multiple dosing of the drug on hepatic CYP3A in vivo. In addition, it is suggested thatKi values corrected by unbound fraction of KTZ and unbound concentrations of the drug in plasma enable precise in vitro-in vivo scaling.
Footnotes
- Abbreviations used are::
- KTZ
- ketoconazole
- CLtot
- total body clearance
- MDZ
- midazolam
- 1′-OH MDZ
- 1′-hydroxymidazolam
- 4-OH MDZ
- 4-hydroxymidazolam
- Vdss
- volume of distribution at steady state
- t1/2β
- half-life in the β-phase
- Received February 7, 2001.
- Accepted July 18, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|